Citigroup’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Citigroup’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-440,892	Closed	-$6.95M	–	5934
2023 Q4	$6.95M	Buy	440,892 +126,390	+40%	+$1.22M	﹤0.01%	1398
2023 Q3	$2.44M	Sell	314,502 -7,938	-2%	-$65.8K	﹤0.01%	1865
2023 Q2	$3.2M	Buy	322,440 +8,201	+3%	+$65.6K	﹤0.01%	1807
2023 Q1	$1.82M	Sell	314,239 -185	-0.1%	-$1.6K	﹤0.01%	2086
2022 Q4	$2.5M	Sell	314,424 -5,183	-2%	-$22.2K	﹤0.01%	1873
2022 Q3	$1.01M	Buy	319,607 +225,276	+239%	+$1.41M	﹤0.01%	2704
2022 Q2	$541K	Buy	94,331 +80,328	+574%	+$627K	﹤0.01%	3164
2022 Q1	$99K	Buy	14,003 +9,182	+190%	+$144K	﹤0.01%	4420
2021 Q4	$110K	Buy	4,821 +3,286	+214%	+$84.9K	﹤0.01%	4685
2021 Q3	$45K	Buy	+1,535	New	+$52K	﹤0.01%	4798

Citigroup's ICVX Position: Q1 2024 in Review

Citigroup sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 440,892 shares — an estimated $6.95M sold.

Citigroup first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $6.95M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Citigroup reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Citigroup sold 440,892 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $6.95M.
Citigroup first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Citigroup's Icosavax, Inc. Common Stock position peaked at $6.95M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.